Tumor markers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are frequently used in screening for pancreatic cancer, but they lack sensitivity or specificity [4]. Here, CEACAM5 is linked to familial pancreatic carcinoma.